Dynavax Technologies

Quarterly Financials

Values in thousands 2024-12-31 2024-09-30 2024-06-30 2024-03-31
Revenue
$72,032
$80,630
$73,795
$50,790
Gross Profit
58,622
67,546
61,810
39,824
EBITDA
12,267
10,082
18,583
-7,854
EBIT
10,196
8,028
16,604
-9,802
Net Income
7,050
17,594
11,386
-8,721
Net Change In Cash
72,032
80,630
73,795
50,790
Free Cash Flow
49,533
18,121
9,934
-17,427
Cash
95,883
119,332
112,501
132,032
Basic Shares
153,022
154,807
154,468
130,199

Annual Financials

Values in thousands 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Revenue
$277,246
$232,284
$722,683
$439,442
Gross Profit
277,246
182,117
460,530
265,870
EBITDA
45,701
9,666
307,699
95,707
EBIT
37,649
2,390
301,031
88,696
Net Income
27,309
-6,389
293,156
76,713
Net Change In Cash
277,246
232,284
722,683
439,442
Cost of Revenue
-233,754
405,529
Free Cash Flow
60,160
96,459
55,577
326,051
Cash
95,883
150,279
202,004
436,189
Basic Shares
133,344
128,733
150,797
133,006

Earnings Calls

Quarter EPS
2024-12-31
$0.05
2024-09-30
$0.12
2024-06-30
$0.08
2024-03-31
-$0.07